Sarah Sydlowski, AuD, PhD, MBA
Cleveland Clinic Main Campus
Treatment & Services
- Assistive Listening Devices Evaluation and Fitting
- Audiologic Evaluation
- Auditory Brainstem Implants
- BAHA (Bone Anchored Hearing Appliance) Implants
- Bone-Anchored Implants
- Cochlear Implants
- Electrophysiologic Monitoring
- Hearing Aids
- Hearing Assistive Technology
- Hearing Implants
- Hearing Needs Assessment
- Single-Sided Deafness
Specialty in Diseases & Conditions
- Hearing Loss
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.View All Plans
About Sarah Sydlowski, AuD, PhD, MBA
Sarah Sydlowski, AuD, PhD, MBA completed her clinical doctorate at the University of Louisville, her externship at Mayo Clinic Arizona, and her PhD at Gallaudet University. Most recently, she completed her executive MBA at the Weatherhead School of Management at Case Western Reserve University where she was the recipient of the EMBA Leadership Award.
Dr. Sydlowski is Audiology Director of the Hearing Implant Program at the Cleveland Clinic where her clinical and research interests focus on implantable hearing devices, optimization of practice efficiency while maintaining strong outcomes, and development of innovative clinical delivery models. Dr. Sydlowski is Board Certified in Audiology with Specialty Certification in Cochlear Implants. She has earned the Cleveland Clinic Distinguished Educator Certificate and is adjunct faculty at the University of Akron where she teaches the graduate Implantable Technologies course.
Dr. Sydlowski has been active in professional organizations, serving on the American Academy of Audiology Board of Directors as a member-at-large (2015-2018) and as President Elect (2020), as President of the Ohio Academy of Audiology (2017) and as a Trustee of the AAA Foundation (2019). She has served on a taskforce for the American Cochlear Implant Alliance related to expanding cochlear implant candidacy and is also Co-Chair of the American Cochlear Implant Alliance Program Committee.
Education & Professional Highlights
Education & Fellowships
Graduate School - Case Western Reserve University School of Medicine
Cleveland, OH USA
Graduate School - Gallaudet University
Washington, DC USA
Graduate School - Mayo Clinic Arizona
Scottsdale, AZ USA
Graduate School - University of Louisville
Louisville, KY USA
Undergraduate - University of Dayton
Dayton, OH USA
- Dangerous Decibels(R) Educator (2015)
American Academy of Audiology Board of Directors (2015-2018; 2020-present)
Ohio Academy of Audiology President (2017)
- Certificate of Clinical Competence in Audiology
- Specialization in Cochlear Implants
Certificate of Clinical Competence in Audiology, Board Certified with Specialty Certification in Cochlear Implants
Awards & Honors
Health Sciences Educator Award nominee (2016)
Weatherhead School of Management EMBA Leadership Award (2020)
Board Certified in Audiology with Specialty Certification in Cochlear Implants (CISC)
Fellow, American Academy of Audiology (FAAA)
Certified Member, American Speech-Language-Hearing Association (CCC-A)
American Cochlear Implant Alliance
American Auditory Society
Ohio Academy of Audiology
Research & Publications
See publications for Sarah Sydlowski, AuD, PhD, MBA.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/19/2022, Dr. Sydlowski has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Fiduciary Role. Dr. Sydlowski serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:
- American Academy of Audiology
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.